Resist
Last-resort antibiotics, first. Delivered to your door for a sniffle.
S24Under InvestigationHealthcareConsumerSubscriptionWhen you get sick, medicine makes you work your way up: first the old drugs, then the better ones, and only at the very end, in a hospital, the ones that actually work on everything. We asked a simple question. Why not start there?
Resist is a direct-to-consumer telehealth subscription for antibiotics of last resort. Scratchy throat? A 90-second async visit gets you the drug hospitals save for when nothing else is left, in a box designed by the agency that did your favorite mattress.
Infectious disease specialists say widespread use will breed resistance and burn through humanity's final line of defense within a decade. We take this seriously. It's why our Series B deck models a ten-year horizon, with an exit in year six.
Our customers aren't thinking about the commons. They have a cold and a meeting on Thursday. We're the only company honest enough to build for that person.
Active founders
Dr. Sterling Haverford-Nakamura
Co-founder & CEO
Board-certified in a specialty he asks us not to name, as the board is reviewing it.
Bianca Trevelyan
Co-founder & CMO
DTC growth marketer. Took a razor brand, a mattress brand and a hair-loss brand to nine figures. "It's the same funnel. The unboxing matters more than people think."